TherapeuticsMD Inc expected to post a loss of 7 cents a share - Earnings Preview

TherapeuticsMD

11/08/2023 16:48

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a fall
in quarterly revenue when it reports  results on August 14
(estimated). 
    * The Boca Raton Florida-based  company is expected to
report  a
98.2% decrease in revenue to $500 thousand from $28.56 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TherapeuticsMD Inc
is for
a loss of 7 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
TherapeuticsMD
Inc is $5​, above​ its last closing price of $4.00. ​​​

This summary was machine generated August 11 at 15:48 GMT.  All
figures in US dollars  unless otherwise stated